Nuvalent, Inc. financial metrics
Professional SEC-based dashboard for profitability, financial health, and growth with transparent scoring logic.
Latest period: Q4 2025.
-
Symbol
-
NUVL on Nasdaq
-
Location
-
Cambridge, MA
-
Fiscal year end
-
31 December
-
Latest financial report
-
26 Feb 2026
Quick Takeaways
- NUVL - Nuvalent, Inc. financial facts are built from SEC company filings data.
- Latest metrics period on this page: Q4 2025.
- Headline metric: Return On Equity -37%.
What Changed
- Return On Equity YoY change: <span class="text-green-600">+25%</span>.
- Most recent SEC facts end date: 31 Dec 2025.
Why This Matters
- This gives a beginner-friendly first read before you inspect detailed formulas and metric tables.
- Every metric card links to a deeper SEC-backed history page for verification.
Official SEC Source
Based on latest 10-Q/10-K
Facts and ratios are grounded in SEC company facts linked to the latest 10-Q/10-K cycle.
See Original Filing
Latest SEC snapshot (2025-12-31) highlights Return On Equity -36.7%, Return On Assets -33.3%, and Current Ratio 15.27x.
Financial Quality Score
Transparent 0-100 scoring model based on profitability, financial health, and growth factors.
20.3/100
Weak
Confidence medium
Return On Equity
-37%
Metric score 0.0/100
Return On Assets
-33%
Metric score 0.0/100
Financial Health
- Current Ratio
- 15.27x
- Debt to Equity
- 0.12x
Watchpoints
Return On Equity, Return On Assets, and Current Ratio
Key metrics snapshot
Return On Equity
-37%
YoY: +25%
Industry median:
-43%
(n=675)
View history
Return On Assets
-33%
YoY: +20%
Industry median:
-47%
(n=673)
View history
Current Ratio
15.27x
YoY: -27%
Industry median:
3.39x
(n=667)
View history
Debt-to-equity
0.12x
YoY: +103%
Industry median:
0.26x
(n=530)
View history
NetIncomeLoss YoY
-63%
YoY:
Industry median:
-0.93%
(n=641)
View history
Profitability
| Metric |
Latest value |
YoY change |
Industry median |
Calendar period |
Fiscal period |
Unit |
|
Return On Equity
|
-37%
|
+25%
|
-43%
(n=675)
|
Q4 2025
|
FY 2025
|
%
|
|
Return On Assets
|
-33%
|
+20%
|
-47%
(n=673)
|
Q4 2025
|
FY 2025
|
%
|
Financial Health
| Metric |
Latest value |
YoY change |
Industry median |
Calendar period |
Fiscal period |
Unit |
|
Current Ratio
|
15.27x
|
-27%
|
3.39x
(n=667)
|
Q4 2025
|
FY 2025
|
x
|
|
Debt-to-equity
|
0.12x
|
+103%
|
0.26x
(n=530)
|
Q4 2025
|
FY 2025
|
x
|
Growth
| Metric |
Latest value |
YoY change |
Industry median |
Calendar period |
Fiscal period |
Unit |
|
NetIncomeLoss YoY
|
-63%
|
|
-0.93%
(n=641)
|
Q4 2025
|
FY 2025
|
%
|
Additional Metrics
| Metric |
Latest value |
YoY change |
Calendar period |
Fiscal period |
Unit |
|
Research and Development Expense
|
$306,970,000
|
+41%
|
Q4 2025
|
FY 2025
|
USD
|
|
General and Administrative Expense
|
$107,337,000
|
+71%
|
Q4 2025
|
FY 2025
|
USD
|
|
Operating Income (Loss)
|
$414,307,000
|
-48%
|
Q4 2025
|
FY 2025
|
USD
|
|
Nonoperating Income (Expense)
|
$10,485,000
|
-151%
|
Q4 2025
|
FY 2025
|
USD
|
|
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest
|
$424,792,000
|
-63%
|
Q4 2025
|
FY 2025
|
USD
|
|
Income Tax Expense (Benefit)
|
$585,000
|
-23%
|
Q4 2025
|
FY 2025
|
USD
|
|
Earnings Per Share, Basic
|
-5.85
|
-49%
|
Q4 2025
|
FY 2025
|
USD/shares
|
|
Earnings Per Share, Diluted
|
-5.85
|
-49%
|
Q4 2025
|
FY 2025
|
USD/shares
|
|
Cash and Cash Equivalents, at Carrying Value
|
$261,745,000
|
+80%
|
Q4 2025
|
FY 2025
|
USD
|
|
Marketable Securities, Current
|
$1,110,207,000
|
+14%
|
Q4 2025
|
FY 2025
|
USD
|
|
Assets, Current
|
$1,392,426,000
|
+23%
|
Q4 2025
|
FY 2025
|
USD
|
|
Other Assets, Noncurrent
|
$20,279,000
|
+118%
|
Q4 2025
|
FY 2025
|
USD
|
|
Assets
|
$1,412,705,000
|
+24%
|
Q4 2025
|
FY 2025
|
USD
|
|
Accounts Payable, Current
|
$30,158,000
|
+477%
|
Q4 2025
|
FY 2025
|
USD
|
|
Employee-related Liabilities, Current
|
$16,935,000
|
+62%
|
Q4 2025
|
FY 2025
|
USD
|
|
Liabilities, Current
|
$91,171,000
|
+69%
|
Q4 2025
|
FY 2025
|
USD
|
|
Other Liabilities, Noncurrent
|
$35,000
|
|
Q4 2025
|
FY 2025
|
USD
|
|
Liabilities
|
$164,366,000
|
+128%
|
Q4 2025
|
FY 2025
|
USD
|
|
Accumulated Other Comprehensive Income (Loss), Net of Tax
|
$2,353,000
|
|
Q4 2025
|
FY 2025
|
USD
|
|
Retained Earnings (Accumulated Deficit)
|
$972,429,000
|
-78%
|
Q4 2025
|
FY 2025
|
USD
|
|
Stockholders' Equity Attributable to Parent
|
$1,248,339,000
|
+17%
|
Q4 2025
|
FY 2025
|
USD
|
|
Liabilities and Equity
|
$1,412,705,000
|
+24%
|
Q4 2025
|
FY 2025
|
USD
|
|
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents
|
$261,745,000
|
+80%
|
Q4 2025
|
FY 2025
|
USD
|
|
Deferred Tax Assets, Valuation Allowance
|
$362,495,000
|
+65%
|
Q4 2025
|
FY 2025
|
USD
|
|
Deferred Tax Assets, Gross
|
$362,765,000
|
+65%
|
Q4 2025
|
FY 2025
|
USD
|
|
Comprehensive Income (Loss), Net of Tax, Attributable to Parent
|
$422,965,000
|
-62%
|
Q4 2025
|
FY 2025
|
USD
|
|
Deferred Tax Assets, Operating Loss Carryforwards
|
$139,120,000
|
+145%
|
Q4 2025
|
FY 2025
|
USD
|
|
Preferred Stock, Shares Issued
|
0
|
|
Q4 2025
|
FY 2025
|
shares
|
|
Preferred Stock, Shares Authorized
|
10,000,000
|
0%
|
Q4 2025
|
FY 2025
|
shares
|
|
Unrecognized Tax Benefits
|
$0
|
|
Q4 2025
|
FY 2025
|
USD
|
|
Preferred Stock, Shares Outstanding
|
0
|
|
Q4 2025
|
FY 2025
|
shares
|
|
Deferred Tax Assets, Net of Valuation Allowance
|
$270,000
|
|
Q4 2025
|
FY 2025
|
USD
|
|
Share-based Payment Arrangement, Expense
|
$86,502,000
|
+43%
|
Q4 2025
|
FY 2025
|
USD
|
|
Preferred Stock, Par or Stated Value Per Share
|
0.0001
|
0%
|
Q4 2025
|
FY 2025
|
USD/shares
|
How we score
This score is transparent and deterministic. We weight profitability, financial health, and growth metrics, then renormalize weights when SEC data is missing.
| Metric |
Weight |
V1 threshold |
| ROIC | 20 | 5% to 20% |
| ROE | 15 | 8% to 25% |
| ROA | 10 | 2% to 10% |
| Operating Margin | 5 | 5% to 25% |
| Current Ratio | 12 | 1.0x to 2.0x |
| Quick Ratio | 8 | 0.8x to 1.5x |
| Debt to Equity | 10 | 0.3x to 2.0x (lower is better) |
| Revenue YoY | 10 | -10% to +20% |
| Net Income YoY | 10 | -10% to +20% |
How Calculated (standard_v1)
Metrics are computed with a market-consensus convention designed for cross-portal comparability.
- TTM Operating Income / TTM Revenues
- Current Assets / Current Liabilities (latest instant quarter)
- (Current Assets - Inventory) / Current Liabilities; fallback: (Cash+Short-Term Investments + Accounts Receivable) / Current Liabilities
- Total Debt / Stockholders Equity (latest instant quarter; shared unit; freshest series)
- TTM Net Income / Average Equity (current quarter + same quarter previous year) / 2
- TTM Net Income / Average Assets (current quarter + same quarter previous year) / 2
- TTM NOPAT / Average Invested Capital, where NOPAT=Operating Income*(1-tax rate), Invested Capital=Equity+Total Debt-Cash & ST Investments
- TTM Revenues YoY
- TTM Net Income YoY
Explore related SEC datasets